ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: SA-PO585

IL-17 Signaling in CD4+ T Cells Controls TH17 Immune Response

Session Information

Category: Glomerular Diseases

  • 1202 Glomerular Diseases: Immunology and Inflammation

Authors

  • Schmidt, Tilman, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Lübbe, Jonas, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Riedel, Jan-Hendrik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Kilian, Christoph, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Krebs, Christian F., University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Paust, Hans-Joachim, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
  • Panzer, Ulf, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Background

The IL-17/IL-17 receptor system plays a crucial role in autoimmune and chronic inflammatory diseases. The biological effects on residential cells are mediated through a heterodimeric receptor complex consisting of IL-17RA and a ligand specific IL-17 receptor subunit (IL-17RB - IL-17RE). However, the expression and function of IL-17 receptors on hematopoietic cells as CD4+ T cells have not been elucidated.

Methods

Crescentic GN (NTN), Psoriasis and C. rodentium colitis were induced in IL-17RA-/-, IL-17RC-/- and in IL-17A, IFNγ and Foxp3 triple-reporter mice for in vivo cell sorting of CD4+ T cell subsets. Single cell RNAseq of CD4+ T cells from the nephritic kidney was performed using the 10X single cell system. pLIVE-plasmid was used to induce IL-17A overexpression in vivo. Moreover, we generated TH17 cell specific IL-17RA gene-deficient mice to study the role of IL-17 signaling in TH17 cells in the NTN model.

Results

Induction of inflammation in the kidney, skin and intestine in IL-17RA-/- mice resulted in an aggravated TH17 cell immune response. Transfer of IL-17RA-/- bone marrow cells in irradiated WT mice indicated IL-17 signaling on hematopoietic cells. CD4+ IL-17 producing WT cells from the inflamed kidney, analyzed with single cell RNAseq, demonstrated a highly activated IL-17 signaling score. mRNA expression analysis of FACS-sorted T cells revealed predominant expression of IL-17RC and IL-17RE by IL-17A+ TH17 cells, whereas IL-17RA is ubiquitously expressed by all CD4+ T cell subsets, demonstrating a T cell specific expression pattern of IL-17 receptors. Systemic overexpression of IL-17A showed a reduction of CD4+ IL-17A+ cells in the kidneys of nephritic mice. Moreover, competitive adoptive transfer experiments of wildtype and IL-17RA-/- or IL-17RC-/- CD4+ T cells into nephritic Rag1-/- mice showed that IL-17 signaling on CD4+ T cells is critically for the control of the pathogenic TH17 response. Mice specifically lacking the IL-17RA receptor in IL-17A+ cells also present an enhanced TH17 cell immune response.

Conclusion

Our findings indicate intrinsic IL-17RA/RC signaling on CD4+ T cells, which regulates the TH17 cell immune response. This novel mechanism might lead to more efficient therapeutic options in targeting IL-17 signaling pathways.